(Q54266394)

27 May 2018

title

Cefoperazone versus ceftriaxone monotherapy of nosocomial pneumonia (English)

1 reference

https://api.crossref.org/works/10.1016/0732-8893(92)90086-9

20 October 2022

0 references

1 reference

R. J. Mangi

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1643821

20 October 2022

K. M. Peccerillo

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1643821

20 October 2022

J. Ryan

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1643821

20 October 2022

C. Berenson

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1643821

20 October 2022

T. Greco

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1643821

20 October 2022

G. Thornton

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1643821

20 October 2022

V. T. Andriole

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1643821

20 October 2022

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=1643821

20 October 2022

publication date

1 July 1992

1 reference

27 May 2018

full work available at URL

https://api.elsevier.com/content/article/PII:0732889392900869?httpAccept=text/xml

1 reference

https://api.crossref.org/works/10.1016/0732-8893(92)90086-9

https://api.elsevier.com/content/article/PII:0732889392900869?httpAccept=text/plain

20 October 2022

1 reference

https://api.crossref.org/works/10.1016/0732-8893(92)90086-9

Diagnostic Microbiology and Infectious Disease

20 October 2022

published in

1 reference

27 May 2018

volume

15

1 reference

27 May 2018

issue

5

1 reference

27 May 2018

page(s)

441-447

1 reference

27 May 2018

Treatment of lower respiratory tract infections with ceftriaxone and cefotaxime. A comparative study.

cites work

1

1 reference

https://api.crossref.org/works/10.1016/0732-8893(92)90086-9

The bacteriology of aspiration pneumonia

20 October 2022

2

1 reference

https://api.crossref.org/works/10.1016/0732-8893(92)90086-9

Mixed Streptococcus pneumoniae and gram-negative bacillary pneumonia in the elderly

20 October 2022

3

1 reference

https://api.crossref.org/works/10.1016/0732-8893(92)90086-9

Randomised comparison of ceftriaxone and cefamandole therapy in lower respiratory tract infections in an elderly population.

20 October 2022

4

1 reference

https://api.crossref.org/works/10.1016/0732-8893(92)90086-9

Nosocomial pneumonia. A multivariate analysis of risk and prognosis.

20 October 2022

5

1 reference

https://api.crossref.org/works/10.1016/0732-8893(92)90086-9

Ceftazidime versus tobramycin-ticarcillin in the treatment of pneumonia and bacteremia

20 October 2022

6

1 reference

https://api.crossref.org/works/10.1016/0732-8893(92)90086-9

Etiologies and characteristic features of pneumonias in a municipal hospital.

20 October 2022

8

1 reference

https://api.crossref.org/works/10.1016/0732-8893(92)90086-9

Cefoperazone versus cefamandole in the treatment of acute bacterial lower respiratory tract infections

20 October 2022

9

1 reference

https://api.crossref.org/works/10.1016/0732-8893(92)90086-9

Aspects of clinical trials with ceftazidime worldwide

20 October 2022

10

1 reference

https://api.crossref.org/works/10.1016/0732-8893(92)90086-9

Multicentered Clinical Evaluation of Cefoperazone for the Treatment of Lower Respiratory Tract Infections

20 October 2022

12

1 reference

https://api.crossref.org/works/10.1016/0732-8893(92)90086-9

Ceftazidime in serious hospital-acquired infections.

20 October 2022

13

1 reference

https://api.crossref.org/works/10.1016/0732-8893(92)90086-9

Nosocomial respiratory infections with gram-negative bacilli. The significance of colonization of the respiratory tract

20 October 2022

14

1 reference

https://api.crossref.org/works/10.1016/0732-8893(92)90086-9

Double-blind, prospective, multicenter trial comparing ceftazidime with moxalactam in the treatment of serious gram-negative infections

20 October 2022

15

1 reference

https://api.crossref.org/works/10.1016/0732-8893(92)90086-9

Hospital-acquired gram-negative rod pneumonias: an overview.

20 October 2022

17

1 reference

https://api.crossref.org/works/10.1016/0732-8893(92)90086-9

Systemic antimicrobial therapy of nosocomial pneumonia: monotherapy versus combination therapy

20 October 2022

18

1 reference

https://api.crossref.org/works/10.1016/0732-8893(92)90086-9

Hospital-acquired pneumonia. Attributable mortality and morbidity

20 October 2022

19

1 reference

https://api.crossref.org/works/10.1016/0732-8893(92)90086-9

Cefoperazone versus combination antibiotic therapy of hospital-acquired pneumonia

20 October 2022

21

1 reference

https://api.crossref.org/works/10.1016/0732-8893(92)90086-9

Cefoperazone versus ceftazidime monotherapy of nosocomial pneumonia

20 October 2022

22

1 reference

https://api.crossref.org/works/10.1016/0732-8893(92)90086-9

Clinical and bacteriologic efficacy of ceftriaxone in the United States

20 October 2022

23

1 reference

https://api.crossref.org/works/10.1016/0732-8893(92)90086-9

Comparative toxicities of third-generation cephalosporins

20 October 2022

24

1 reference

https://api.crossref.org/works/10.1016/0732-8893(92)90086-9

Clinical trials of cefotaxime for the treatment of bacterial infections of the lower respiratory tract

20 October 2022

25

1 reference

https://api.crossref.org/works/10.1016/0732-8893(92)90086-9

Use of ceftazidime in the treatment of nosocomial lower respiratory infections

20 October 2022

27

1 reference

https://api.crossref.org/works/10.1016/0732-8893(92)90086-9

Bacterial Pneumonia in the Elderly

20 October 2022

28

1 reference

https://api.crossref.org/works/10.1016/0732-8893(92)90086-9

Treatment of respiratory infections in the patient at risk

20 October 2022

29

1 reference

https://api.crossref.org/works/10.1016/0732-8893(92)90086-9

20 October 2022

Identifiers

1 reference

27 May 2018

1 reference

27 May 2018